CPET System Segment Leads Global Cardiopulmonary Stress Testing Systems Market


Posted February 24, 2016 by ranutmr

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure.

 
Transparency Market Research has recently published a report on the global cardiopulmonary stress testing system market , which presents insights into the prevalent market dynamics and studies the factors that are likely to drive or hamper the overall market. The report is titled “Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” and is available on the company website for sale. The global cardiopulmonary stress testing market, states the report, was valued at US$3.3 bn in 2014 and is expected to reach US$6.6 bn by 2023. If the figures hold true, the market will exhibit a positive CAGR of 8.20% during the period.














Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530


The cardiopulmonary stress testing systems market comprises devices that assist in the evaluation of exercise capacity of an individual and predict outcome in patients diagnosed with heart failure. The primary goal of cardiac stress testing is to identify the risk stratification of coronary artery disease (CAD), which is one of the most common causes of deaths globally. Diagnosis and monitoring of cardiopulmonary disorders is rapidly gaining importance in the health care industry in order to prevent the rapid rise in deaths due to increasing prevalence of various cardiovascular and pulmonary disorders. Factors such as aging population, rising incidence of cardiopulmonary disorders, and increasing awareness about the risks associated with cardiopulmonary disorders would contribute to the growth of the cardiopulmonary stress testing systems market. Furthermore, global increase in the number of hospitals is likely to generate fresh demand for cardiopulmonary stress testing systems.

The global cardiopulmonary stress testing systems market has been segmented on the basis of product type and geography. Based on product type, the cardiopulmonary stress testing systems market has been categorized into five key segments: cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). Cardiopulmonary exercise testing (CPET) systems have been categorized into two sub-segments: portable CPET systems and stationary CPET systems. CPET was the largest segment of the global cardiopulmonary stress testing systems market. Rise in prevalence of cardiac diseases, rapid growth in geriatric population, and technical advancements are the major factors boosting the global cardiopulmonary stress testing systems market. Furthermore, rise in incidence of coronary artery disease, increase in lifestyle disorders, and growth in disposable income are likely to propel the market during the forecast period.

Geographically, North America held the largest share of the global cardiopulmonary stress testing systems market in terms of revenue in 2014, followed by Europe. These two regions are expected to retain their leadership positions throughout the forecast period from 2015 to 2023. The dominance of these two regions was majorly due to large pool of cardiopulmonary patients and presence of a large number of hospitals that are increasingly adopting innovative products. China and India are the major markets in Asia-Pacific that offer large opportunities for cardiopulmonary stress testing systems manufacturers. The cardiopulmonary stress testing systems market in Asia-Pacific is projected to expand at the highest CAGR during the forecast period. Brazil and Mexico are the major countries in Latin America where the cardiopulmonary stress testing systems market is expected to record strong growth.

Philips Healthcare, GE Healthcare, CareFusion Corporation, Spacelabs Healthcare, COSMED, MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc. and Welch Allyn are the major players operating in the global cardiopulmonary stress testing systems market. Philips Healthcare, GE Healthcare, CareFusion Corporation, and Spacelabs Healthcare operate in most of the segments of the cardiopulmonary stress testing systems market at a global level.

Contact us:

Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Marketing , Medical
Tags segmentation , cardiopulmonary stress testing systems market forecasts , demand , opportunities
Last Updated February 24, 2016